1 1 Neuropathic pain caused by peripheral nerve injury significantly affects sensory perception and 1 2 quality of life. Accumulating evidence strongly link cholesterol and inflammation with 1 3 development and progression of Obesity and Diabetes associated-neuropathies. However, the 1 4 exact mechanisms of how lipid metabolism in peripheral nervous system (PNS) contributes to 1 5
Introduction 4
Peripheral neuropathy arising from metabolic disorders such as Obesity and pre-diabetes leads 5 to loss of sensory perception, pain, and reduced quality of life 1-3 . Currently, there are no disease 6 modifying drugs available, as the neurobiology underlying the neuropathic pain is still unclear. 7 Many previous studies have focused on glucose as a major culprit in the development of 8 Obesity-associated neuropathies 4-6 , but recent body of evidence indicated that altered plasma 9 lipid signaling in the peripheral nervous system (PNS) 7-10 is involved. Indeed, evidence on 1 0 obese and diabetic patients, and murine model of Type II diabetes strongly suggest that 1 1 circulating cholesterol and inflammation are linked to development and progression of 1 2 neuropathy [11] [12] [13] . However, the mechanisms underlying how lipids affect cells of the PNS are still 1 3 unclear. Notably, sensory neurons located in the dorsal root ganglia (DRG) and associated 1 4
Schwann cells (SC), satellite cells or immune cells in the nerves are not protected from the 1 5 blood-brain or blood-nerve barrier 14 suggesting that, in contrast to the central nervous system 1 6 (CNS), they could sense and/or be affected by circulating lipids. Previously, we have found that 1 7 peripheral neurons express liver X receptors (LXR α /β) among other lipid sensors [15] [16] [17] . LXR α /β 7 synthesis (Srebf1/Srebp-1c), and confirmed that their expressions were increasing following 1 LXR activation (Figure3E) . These data demonstrate that LXRs are transcriptionally active in 2 DRG neurons. To test the activity of LXRs in the presence of saturated fatty acid, transduced 3 neurons with the lentivector reporter were treated with palmitic acid followed by GW3965 4 stimulation. Palmitate treatment significantly lowered the increase in luminescence induced by 5 GW3965 (Figure3D) . These findings confirm that LXR activity and its canonical gene 6 expressions are altered in Obesity in neurons as in many other tissues 16, 40, 41 . Next, we hypothesized that LXR could regulate Nrg1 gene expression. To evaluate the effect of 9 LXR activation on the Nrg1-type III expression in normal and in an obesogenic environment, we To test whether GW3965 regulates Nrg1-type III expression in sensory neurons, NC or WD-fed 2 0 RiboTag-Nav mice or palmitate-stimulated DRG organotypic cultures from RiboTag-Nav mice 2 1 were treated with GW3965 as describe above. Compared to NC-fed RiboTag-Nav, sensory and GW3965 treatment attenuated this decrease (Figure4D, E). Overall data suggest that LXR 2 4 α /β regulate Nrg1 expression in the sensory neurons of the DRG. Our findings also suggest that 2 5 the decrease in Nrg1 mRNA level observed in vivo in the nociceptors of obese mice i) may be 2 6 8 the consequence of a decrease in LXR activity(induced by diet and/or saturated fatty acids) and 1 ii) could be rescued by GW3965. processed to assess the mRNA levels of LXR canonical pathway and Nrg1. As shown in 1 2 Figure5B, Abca1 was decreased more than two fold in both NC and WD-fed LXRabnav mice. expression in sensory neurons in vivo and that WD feeding may alter this regulation (Figure5B). As mentioned above, DRG contains cell bodies of axons that compose the sciatic nerve and are 2 0 associated with myelinating or non-myelinating SC. As Axonal Nrg1 is known to determine SC 2 1 function 26,27 , we isolated sciatic nerves from LXRab and LXRabnav mice to assess gene 2 2 expression involved in lipid metabolism that were previously shown to be downstream of 2 3 Nrg1/ErbB [25] [26] [27] 30 : Srebf1/Srebp-1c, myelin protein zero (MPZ), and peripheral myelin protein 2 4 (PMP22) were evaluated. We rigorously dissected the nerve to harvest the same piece of tissue 2 5 in each experiment. In pilot data, the number of cells isolated were counted, the total number of 2 6 9 total cells were similar between all experiments (not shown). Interestingly, Srebf1/Srebp-1c 1 expression increased in WD-fed mice sciatic nerve compared to NC-fed mice (Figure5C). We 2 did not observe any differences between genotypes suggesting that Srebp1f change following and LXRabNav mice using electron microscopy, but we did not see any significant changes in 1 0 SC number or structure in either Remak bundles (non-myelinated SC) or myelinating SC 1 1 associated with the nerve (Figure5E). It is also possible that the change in gene expression is 1 2 seen at an earlier time point than that of the change in structure or that the EM fails to capture 1 3 these changes. Cell-specific models (e.g -cre) allowing to specifically purify SC non-myelinating 1 4 and myelinating would be necessary to quantify in vivo the numbers of all SC and also to 1 5 directly purify mRNA. Unfortunately, these models do not exist, the current knowledge on SC 1 6 rely on in vitro experiment using SC cultures. These changes in neuron-nerve associated cell 1 7 signaling may be involved -at least in part-in the mechanical and thermal hypersensitivity 1 8 observed in obese mouse model lacking LXR in sensory neurons (as published 16,32 ). Human studies showed correlation between circulating cholesterol and lipids in development ligand-activated nuclear receptors that bind metabolites of cholesterol 18, 19 . While LXRα/β is 2 4 described in many reports as being an important pathway involved in many neurodegenerative 2 5 diseases 36,37 , its specific role in CNS and PNS cells remains unclear and likely pleiotropic. Our 2 6 10 current data suggest that LXRα/β may drive a unique transcriptional program regulating neuron-1 nerve-associated cells (likely SC) interactions that may sustain peripheral nerve function. Our 2 findings using mice models (WD-fed and LXRα/β sensory neuron specific deletion) and ex vivo 3 (DRG organotypic and primary neuron cultures), show that WD alters LXR activity that changes 4 Nrg1 expression leading to neuron-SC communication impairment in the PNS. LXR activation 5 had been shown to improve WD-induced neuropathy 16 . It is possible that LXR/Nrg1/ErbB 6 pathway explain in part this improvement. functionally modulated by Nrg1. ErbB2 and ErbB3 receptors are required for signal transduction in the Schwann cells, but 2 4
ErbB3, but not ErbB2, binds extracellular ligands with high affinity, however ErbB3 is 2 5 catalytically inactive, and ErbB2 contributes to the tyrosine kinase activity essential for 2 6 11 signaling 45 . Disruption of Nrg1/ErbB interaction leads to abnormal and aberrant myelination of 1 large fibers and perturbation in the Remak bundle containing small non-myelinated axons 2 resulting in abnormal nerve conduction and altered nerve structure 30, 31 . Regulation of SC lipid 3 synthesis via Srebf1 is one of the primary transcriptional responses following Nrg1-ErbB2/3 4 stimulation 46 . The mechanism of action of Nrg1 is not clear in non-myelinated fibers and needs 5 to be better defined. provide another mechanism to explore and understand the role of LXR in the SC function. Previous studies from others and our group showed that signaling pathway in the neurons of the 1 9 DRG is disrupted inducing cellular stress 16, 32, 38, 47 . Our previous data showed that activation of 13 total) (Envigo, Indiana, USA) for 12 weeks starting at weaning 16, 17 . All studies mentioned were 1 done exclusively using male mice to avoid confounding effect of hormones with experimenter 2 blinded to both treatment and genotype. In vivo agonist treatment. WT and RiboTag mice were treated with vehicle or LXR agonist 1 6 (GW3965; 25mg/kg BW) (Axon Medchem, Virginia, USA) by i.p. twice a week for 3 weeks 1 7 starting at 8 weeks on WD as reported before 16 . Tissues were rapidly dissected and frozen in 1 8 liquid nitrogen before analysis. Tissue from RiboTag mice were harvested and processed as 1 9 detailed below. replacing every other day in a 37ºC and 5% CO 2 incubator. After an overnight incubation in low 2 5 serum (2.5%) MEM supplemented with GlutaMAX (2mM), DRG were stimulated with either 2 6 14 vehicle or 15µM GW3965 for 24 hrs before palmitate treatment (400 µM) for another 24hrs as 1 described previously 16 . RNA was extracted using Acturus PicoPure RNA Extraction Kit (Applied 2 Biosystems, California, USA).
3 4 Enrichment of transcripts from sensory neurons. DRG from RiboTag+/+:Nav1.8Cre+/-mice 5 were either freshly harvested for RNA isolation or harvested to perform organotypic culture 6 followed by RNA isolation. To isolate RNA associated with HA-tagged ribosomes in sensory 7 neurons, immunoprecipitation (IP) followed by mRNA purification following the procedure 8 published by Sanz et al. was used 16, 49 . Briefly, DRG were homogenized in homogenization 9 buffer and supernatant removed after centrifuging at 10,000g for 10 min at 4ºC. 10% of the 1 0 homogenate was saved (input) for mRNA isolation. Remaining volume was incubated at 4ºC 1 1 with anti-HA antibody (Biolegend, #901513) at 1:150 dilution for 4hrs on a gentle spinner. This is 1 2 followed by an overnight incubation at 4ºC on a gentle spinner with above sample transferred to axotomized DRG were then transferred to a collagenase A/trypsin mix (1.25mg/ml each) and 2 5 incubated for 30min. Partially digested DRG were then passed through fire polished glass 2 6 15 pipettes followed by 3min spin at 3000g. After careful removal of supernatant, cells were 1 resuspended in advanced DMEM with 10% FBS and 4mM GlutaMAX, and plated onto a poly-l-2 lysine coated plates. Neuronal cultures were maintained in a 37ºC and 5% CO 2 incubator for 3-4 3 days changing above media supplemented with Ara-C (2µM) to inhibit replicative cells every 4 other day before treating the cells to extract RNA as described above. Total RNA was extracted from Sciatic nerve of NC-or WD-fed mice with Arcturus PicoPure RNA 1 7 isolation kit (Applied Biosystems). Two biological replicates were used for each group. Total RNA Pico Chip. Total RNA samples that passed QC were used as input for library construction. NextSeq 500 NGS System. Single 75 bp reads were generated with dual indexing. RNA-seq 2 6 1 using FastQC. Reads were trimmed to remove Illumina adapters from the 3' ends using 2 cutadapt 52 . Trimmed reads were aligned to the Mus musculus genome (mm10) using STAR 53 .
3
Read counts for each gene were calculated using htseq-count 54 in conjunction with a gene 4 annotation file for mm10 obtained from Ensembl (http://useast.ensembl.org/index.html).
5
Normalization and differential expression were calculated using DESeq2 that employs the Wald 6 test 55 . The cutoff for determining significantly differentially expressed genes was an FDR-7 adjusted p-value less than 0.05 using the Benjamini-Hochberg method. test was used as appropriate and multiple comparisons were performed using ANOVA. For and RB were involved in data collection, assembly, analysis and interpretation of data. CKG and 2 5 VM-A drafted the manuscript. CKG, VM-A, and RB reviewed the manuscript.
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